RUFIJI District | KILOMBERO/ ULANGA Districts | |
---|---|---|
Probable ADR events detected by passive surveillance: | ||
SP monotherapy | 7 | 13 |
Artesunate monotherapy | 0 | 0 |
Combination of AS/SP | 3 | 0 |
Total | 10 | 13 |
Probable ADR events detected by active surveillance: | ||
SP monotherapy | 2 | 7 |
Artesunate monotherapy | 0 | 0 |
Combination of AS/SP | 2 | 0 |
Total | 4 | 7 |
Total probable ADR events detected: | ||
SP monotherapy | 9 | 20 |
Artesunate monotherapy | 0 | 0 |
Combination of AS/SP | 5 | 0 |
Total | 14 | 20 |
Total Population Under DSS Surveillance | 84,500 | 74,200 |
Estimates of average annual anti-malarial drug exposure rates in the DSS areas per capita: | ||
SP monotherapy | 0.46 | 0.54 |
Artesnuate monotherapy | 0.37 | 0 |
Combination of AS/SP | 0.53 | 0 |
Estimate of total doses used by the DSS population in 2004/5 (population * average annual exposure) | ||
SP monotherapy | 38,870 | 40,068 |
AS monotherapy | 31,265 | 0 |
Combination of AS/SP | 44,785 | 0 |
Estimated ADR incidence per 100,000 exposures 1 | ||
SP monotherapy | 11.6 | 25.0 |
AS monotherapy | 0 | - |
Combination of AS/SP | 5.6 | - |